CIK 0001664710
- Non-accelerated filer
- Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811173868
- Phone
- +1 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,619
- in 1 filing, $6K under 10b5-1 plans
Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-27 | Knowles Julius Director | Sale | −17,854 | $40.51 | $723K | 327,731 |
| 2021-09-27 | Knowles Julius Director | Sale | −20,292 | $41.52 | $843K | 466,957 |
| 2021-09-27 | Knowles Julius Director | Sale | −13,233 | $41.52 | $549K | 314,498 |
| 2021-09-27 | Knowles Julius Director | Sale | −10,018 | $42.29 | $424K | 456,939 |
| 2021-09-27 | Knowles Julius Director | Sale | −6,532 | $42.29 | $276K | 307,966 |
| 2021-08-17 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +1,293 | $0.30 | $388 | 85,700 |
| 2021-08-17 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −1,293 | 0 | ||
| 2021-08-10 | Cooper Simon Peter Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2021-07-02 | Knowles Julius Director | Sale | −8,627 | $41.08 | $354K | 520,411 |
| 2021-07-02 | Knowles Julius Director | Sale | −5,626 | $41.08 | $231K | 349,361 |
| 2021-07-02 | Knowles Julius Director | Sale | −5,789 | $41.72 | $242K | 514,622 |
| 2021-07-02 | Knowles Julius Director | Sale | −3,776 | $41.72 | $158K | 345,585 |
| 2021-07-01 | Knowles Julius Director | Sale | −13,268 | $41.22 | $547K | 530,196 |
| 2021-07-01 | Knowles Julius Director | Sale | −8,650 | $41.22 | $357K | 355,745 |
| 2021-07-01 | Knowles Julius Director | Sale | −1,112 | $41.89 | $47K | 529,084 |
| 2021-07-01 | Knowles Julius Director | Sale | −728 | $41.89 | $30K | 355,017 |
| 2021-07-01 | Knowles Julius Director | Sale | −46 | $42.75 | $2K | 529,038 |
| 2021-07-01 | Knowles Julius Director | Sale | −30 | $42.75 | $1K | 354,987 |
| 2021-06-24 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +6,500 | $0.30 | $2K | 84,407 |
| 2021-06-24 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −6,500 | 1,293 |
Page 17 of 36 · 707 trades